# Specification Quality Checklist: CH EMED EPR (CARA EMED)

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-11-08
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- Document types (PMLC, PRE, MTP) were decided by the user before the spec was written; DIS, PADV
  and PML follow later.
- Clarified 2026-11-08: no composed CHMED16A ↔ CH EMED EPR conversion; CH EMED EPR converts
  only to and from CH EMED (FR-004).
- Defaults taken instead of clarification markers, worth confirming with `/speckit-clarify`:
  a card becomes PMLC unless treatment plans are requested (FR-003); a CH EMED EPR document
  declared as general CH EMED is accepted (edge cases).
- Names of FHIR standards, IG packages and document types (PMLC, PRE, MTP, PDF/A) are domain
  terms of the formats, not implementation details, as in the earlier specs.
- The assumption that CH EMED EPR → CH EMED loses no clinical data is to be verified against the
  official examples in the plan.
